Why the study?
Does maternal vitamin A or retinoic acid administration prevent obesity in offspring by promoting beige adipogenesis and vascular development?
Does maternal vitamin A or retinoic acid administration prevent obesity in offspring by promoting beige adipogenesis and vascular development?
Maternal retinoid administration promotes beige adipogenesis and vascular development in offspring, offering a potential therapeutic strategy to prevent obesity in progeny.
Answers are grounded in this paper and cite their sources.
Suggests maternal retinoid supplementation may offer a novel pathway to prevent offspring obesity; leaves open whether.
Maternal vitamin A intake varies but its impact on offspring metabolic health is unknown. Here we found that maternal vitamin A or retinoic acid (RA) administration expanded PDGFRα + adipose progenitor population in progeny, accompanied by increased blood vessel density and enhanced brown-like (beige) phenotype in adipose tissue, protecting offspring from obesity. Blockage of retinoic acid signaling by either BMS493 or negative RA receptor (RARαDN) over-expression abolished the increase in blood vessel density, adipose progenitor population, and beige adipogenesis stimulated by RA. Furthermore, RA-induced beige adipogenesis was blocked following vascular endothelial growth factor receptor (VEGFR) 2 knock out in PDGFRα + cells, suggesting its mediatory role. Our data reveal an intrinsic link between maternal retinoid level and offspring health via promoting beige adipogenesis. Thus, enhancing maternal retinoids is an amiable therapeutic strategy to prevent obesity in offspring, especially for those born to obese mothers which account for one third of all pregnancies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: